(Total Views: 111)
Posted On: 02/14/2023 10:45:49 AM
Post# of 144784
$CGEN News Article - Rilvegostomig, AstraZeneca's Bi-specific Antibody Derived from Compugen's COM902, Expected to Progress into Phase 3 https://marketwirenews.com/news-releases/rilv...98129.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
